MedTech Week Magazine 2019 At a glance
Highlights from the 5th Edition of the Award-Winning MedTech Week Magazine
2,5
million
views
I am particularly pleased to see so many examples of companies reaching out to their communities and engaging with employees – after all, medtech is really about people rather than technology.
22
Countries
Engaged
51
Members
Involved
55
External
Partners
3,300
new fans & followers
37,000
website visits
140,000
video views
Bringing Sound & Vision to the message
Articles
Guessing games
Fun video series saw kids trying to figure out what medical devices do
Delivering value that’s valued
A series of blogs, videos and case studies offered a global view of value in healthcare
Paying for digital health
Digital technologies could transform patient care – but how are they reimbursed?
Patient Safety First
National associations help companies deliver products of the highest quality
Safer sleep
Remote monitoring technology is revolutionising sleep apnoea treatment
Demystifying nuclear medicine
Press trip offers journalists insights on the latest in PET/MRI technology
A job for life
Careers in medtech offer a rewarding way to help transform and save lives every day
Fighting antimicrobial resistance (AMR)
Diagnostic tests are the invisible heroes of the healthcare system. Between 60 and 70% of all medical decisions are based on the results of diagnostic tests, but medical biology represents only 2-3% of healthcare expenditures.
Career choices
Apprenticeship Night was a chance for companies to engage with young people
When plastic heals
Translating material properties into life-saving products
Perspectives
New role for Clinical Research Organisations
Two new EU Regulations will require the collection and analysis of more data during clinical investigations
Green is the new black
Climate action is rightfully gaining space on the policy agenda. Healthcare is part of the problem and must become part of the solution.
Improving the lives of people living with diabetes
It is incredible when I think that nearly 100 years have passed since the discovery of insulin. Since then, insulin has saved the lives of millions of people living with diabetes around the world.
What do patients want?
Patients don’t care about technology – they care about the quality of life
Career inspiration: My journey to biomedical engineering
At the age of seventeen, I was good at maths and sciences, but I did not know what to study after secondary school.
Are you ready for Eudamed?
One of the biggest changes on the healthcare horizon will be new EU requirements for product information. If you are not already preparing for this, start now – the clock is ticking.
Changing health, changing lives
Our sector has changed a great deal in the last decade, but there is much more innovation to come – notably in customisation and data.
Incontinence: Breaking the taboo
The condition can be treated, often cured, and always managed
‘Will it make the boat go faster?’
We need to work in partnership with healthcare providers to understand the true value of technologies.
The future of medicine is personal
We must all play our part in embedding personalised medicine into Europe’s healthcare systems
The future of medicine is personal
We must all play our part in embedding personalised medicine into Europe’s healthcare systems
Denis Horgan
Executive Director, European Alliance for Personalised Medicine
In the near future, healthcare services will increasingly deliver the right intervention to the right person at the right time, improving the outcomes for patients and cutting down unnecessary treatments.
Personalised medicine can also play a major role in prevention. Genome sequencing, for example, can identify patients at risk of developing disease, while state-of-the-art imaging, vaccinations and screening can reduce their risk of ill-health.
To ensure that this approach goes mainstream across the EU, there is a need for agreement on standards, and improvements to regulatory pathways, as well as an appropriate regulatory and medical framework.
Alongside this, given the reality that many common medicines are not effective in treating large numbers of the patients they are supposed to help, personalised medicine offers a promising alternative.
This tailor-made treatment strategies for individuals or groups of individuals permit patients to receive the specific therapies that work best for them, eliminating waste on trial and error.
Unfortunately, at present, regulatory and reimbursement systems are not adapted to respond to the new opportunities that these novel therapeutics offer.
Greater understanding could help unleash waves of new medicines that would improve patients' lives, and transform society's approach to healthcare. For EU policymakers and healthcare stakeholder, this is our shared task for the next five years – we must rise to occasion to accelerate the adoption of personalised care.
